Reports and Presentations
This report contains the maintenance of effort (MOE) information for each federal grant received by HHSC as of September 2021.
Rider 52 requires HHSC to submit a report that provides information about actual annual expenditures from the previous fiscal year for all opioid-related programs at HHSC, DFPS and DSHS.
The Implementation Plan includes key milestones and identified interagency dependencies for the development of pro forma modeled rates and cost report-based rates, and for the implementation of all other recommendations related to reimbursement rate methodologies made in the report entitled “Foster Care Methodology as required by the 2020-21 General Appropriations Act, House Bill 1, 86th Legislature, Regular Session, 2019 (Article II, Special Provisions Relating to All Health and Human Services Agencies, Section 32),” as directed by Special Provision 26(e)(1).
This executive brief is an overview of the activities and findings from the state fiscal year (SFY) 2020 Summary of Activities (SOA) report meant to highlight the key findings from prior year EQRO activities.
This executive brief is an overview of the activities and findings from the state fiscal year (SFY) 2019 Summary of Activities (SOA) report meant to highlight the key findings from prior year EQRO activities.
This presentation provides an overview of the rates-setting process, the development of managed care capitation rates, and managed care organization performance and accountability.
This presentation provides an overview of HHS Information Technology, including the agency's 10-Year IT Modernization Plan.
This presentation covers HHSC's procurement and contracting reform activities, including current and future improvement efforts. It also addresses the agency's response to a January 2021 report by the State Auditor's office.
This presentation provides an overview of HHSC program areas and topics relevant to the House Committee on Human Services. It includes information on agency preparation and response to the February 2021 winter storm and the agency's response to COVID-19.
The Update provides FY 2002-2019 data on the use of psychotropic medications for children in Texas foster care based on Medicaid prescription and medical claims.